Modern trends in diuretics development

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• Diuretics are essential treatments for prevalent cardiovascular and kidney diseases like hypertension, edema, and heart failure.
• Existing diuretics have a generally favorable risk/benefit profile but are associated with side effects.
• Increasing disease prevalence necessitates the development of novel diuretics with improved pharmacological profiles.

Purpose of the Study:

• To provide an overview of medicinal chemistry strategies for developing small molecule diuretics.
• To identify and discuss promising diuretic drug candidates discovered in the last decade.
• To explore novel therapeutic targets and compound classes for diuretic activity.

Main Methods:

• Review of recent scientific literature on diuretic drug discovery.
• Analysis of medicinal chemistry approaches for small molecule development.
• Identification of novel diuretic agents based on high-throughput screening and chemical modification.

Main Results:

• Several classes of small molecule diuretics show promise, including vasopressin receptor antagonists, SGLT2 inhibitors, and urea transporter inhibitors.
• Emerging targets include aquaporin antagonists, adenosine receptor antagonists, and natriuretic peptide receptor agonists.
• Inhibitors of ROMK, WNK-SPAK, and pendrin represent other actively researched areas for diuretic development.

Conclusions:

• Medicinal chemistry advancements facilitate the discovery of novel diuretic agents.
• New drug candidates offer potential for improved treatment of cardiovascular and kidney diseases.
• Continued research into diverse molecular targets is crucial for advancing diuretic therapy.